X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23590) 23590
Magazine Article (73) 73
Newsletter (56) 56
Book Chapter (48) 48
Newspaper Article (24) 24
Book / eBook (7) 7
Dissertation (6) 6
Web Resource (4) 4
Book Review (2) 2
Publication (2) 2
Reference (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18219) 18219
reverse transcriptase polymerase chain reaction (11772) 11772
male (8683) 8683
female (8314) 8314
animals (7787) 7787
hiv infections - drug therapy (6007) 6007
reverse transcriptase inhibitors - therapeutic use (5611) 5611
adult (5123) 5123
blotting, western (4580) 4580
mice (4466) 4466
middle aged (4210) 4210
oncology (4148) 4148
anti-hiv agents - therapeutic use (4056) 4056
infectious diseases (3602) 3602
gene expression (3467) 3467
expression (3453) 3453
immunology (3108) 3108
pharmacology & pharmacy (3102) 3102
research (2991) 2991
cancer (2783) 2783
hiv (2720) 2720
rna, messenger - genetics (2707) 2707
apoptosis (2705) 2705
cell line, tumor (2561) 2561
hiv infections - virology (2504) 2504
virology (2432) 2432
drug therapy, combination (2409) 2409
research article (2339) 2339
immunohistochemistry (2334) 2334
analysis (2302) 2302
hiv-1 - drug effects (2289) 2289
proteins (2286) 2286
health aspects (2199) 2199
mutation (2188) 2188
cells, cultured (2120) 2120
aged (2118) 2118
rats (2114) 2114
cell biology (1965) 1965
medicine (1904) 1904
genetic aspects (1893) 1893
viral load (1883) 1883
multidisciplinary sciences (1765) 1765
hiv-1 - genetics (1754) 1754
biochemistry & molecular biology (1742) 1742
treatment outcome (1739) 1739
antiretroviral therapy (1668) 1668
hiv protease inhibitors - therapeutic use (1656) 1656
rna, messenger - metabolism (1645) 1645
therapy (1638) 1638
science (1590) 1590
real-time polymerase chain reaction (1558) 1558
physiological aspects (1521) 1521
lamivudine - therapeutic use (1516) 1516
activation (1514) 1514
care and treatment (1508) 1508
flow cytometry (1499) 1499
rna (1468) 1468
cell proliferation (1453) 1453
antiviral agents (1434) 1434
microbiology (1433) 1433
drug therapy (1410) 1410
biology (1391) 1391
cells (1387) 1387
gene-expression (1380) 1380
in-vitro (1363) 1363
cell line (1322) 1322
reverse transcriptase inhibitors - pharmacology (1319) 1319
cd4 lymphocyte count (1313) 1313
reverse transcriptase inhibitors - administration & dosage (1289) 1289
drug resistance (1285) 1285
reverse transcriptase inhibitors - adverse effects (1281) 1281
signal transduction (1280) 1280
polymerase chain reaction (1260) 1260
gene expression profiling (1251) 1251
anti-hiv agents - pharmacology (1236) 1236
tumors (1236) 1236
reverse-transcriptase (1232) 1232
time factors (1232) 1232
tumor cells, cultured (1222) 1222
hiv-1 (1199) 1199
hiv infection (1184) 1184
protease inhibitors (1179) 1179
infection (1176) 1176
mice, inbred c57bl (1173) 1173
apoptosis - drug effects (1171) 1171
aids (1170) 1170
inflammation (1168) 1168
rodents (1157) 1157
human-immunodeficiency-virus (1140) 1140
medicine, research & experimental (1129) 1129
genes (1121) 1121
oligonucleotide array sequence analysis (1119) 1119
adolescent (1117) 1117
gene expression regulation, neoplastic (1114) 1114
enzyme-linked immunosorbent assay (1108) 1108
kinases (1107) 1107
prognosis (1104) 1104
reverse-transcriptase inhibitors (1099) 1099
resistance (1086) 1086
risk factors (1066) 1066
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23338) 23338
Spanish (140) 140
French (98) 98
German (93) 93
Japanese (76) 76
Chinese (61) 61
Russian (24) 24
Italian (18) 18
Polish (14) 14
Dutch (12) 12
Danish (5) 5
Korean (5) 5
Portuguese (5) 5
Romanian (4) 4
Serbian (4) 4
Hungarian (2) 2
Turkish (2) 2
Catalan (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 10/2014, Volume 161, Issue 7, pp. 461 - 471
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals
Journal Article
Journal of antimicrobial chemotherapy, ISSN 1460-2091, 2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 785 - 792
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9622, pp. 1417 - 1426
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 5/2009, Volume 199, Issue 9, pp. 1275 - 1285
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0171596 - e0171596
Objectives Two nucleos(t) ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy... 
TRANSMITTED DRUG-RESISTANCE | RISK-FACTORS | VIRUS-INFECTION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | INFECTED PATIENTS | HIV-1-INFECTED PATIENTS | NEVIRAPINE USE | HEPATITIS-C | ADVERSE EVENTS | PROTEASE INHIBITORS | Humans | Middle Aged | Male | RNA, Viral - blood | Alanine Transaminase - blood | Viral Load | Incidence | Reverse Transcriptase Inhibitors - adverse effects | Young Adult | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Chemical and Drug Induced Liver Injury - enzymology | Chemical and Drug Induced Liver Injury - etiology | Severity of Illness Index | Drug Eruptions - etiology | Nucleosides - therapeutic use | Anti-HIV Agents - adverse effects | Risk Factors | Chemical and Drug Induced Liver Injury - epidemiology | CD4 Lymphocyte Count | Nucleosides - adverse effects | Viremia - drug therapy | Aspartate Aminotransferases - blood | Taiwan - epidemiology | HIV Infections - drug therapy | Disease Management | Drug Eruptions - epidemiology | Nevirapine | Toxicity | Exanthema | Viruses | Drug resistance | Efavirenz | Confidence intervals | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Division | Hepatitis B virus | Hepatotoxicity | Antiretroviral drugs | Hepatitis B surface antigen | Statistical analysis | Regression analysis | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Inhibitors | Protease inhibitors | Womens health | Nucleosides | Skin | Hepatitis C virus | Hepatitis C | Index Medicus | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2014, Volume 346, Issue 6212, pp. 1000 - 1003
Nucleoside reverse transcriptase inhibitors (NRTIs) are mainstay therapeutics for HIV that block retrovirus replication. Alu... 
T lymphocytes | Medical research | Phosphorylation | Transfection | RNA | HEK293 cells | Cell death | REPORTS | Nucleosides | Research grants | Dosage | P2X7 RECEPTOR | PATHOGENESIS | INTERLEUKIN-18 | P2X RECEPTOR | INFLAMMASOME ACTIVATION | MULTIDISCIPLINARY SCIENCES | MACULAR DEGENERATION | NLRP3 INFLAMMASOME | ATP RELEASE | VERSUS-HOST-DISEASE | CASPASE-1 ACTIVATION | Retinal Pigment Epithelium - metabolism | Apoptosis - drug effects | NLR Family, Pyrin Domain-Containing 3 Protein | Reverse Transcriptase Inhibitors - pharmacology | Caspase 1 - metabolism | Geographic Atrophy - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Hepatitis - drug therapy | Animals | Carrier Proteins - metabolism | Choroidal Neovascularization - drug therapy | Graft vs Host Disease - drug therapy | Inflammasomes - drug effects | Liver - drug effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Retinal Pigment Epithelium - physiology | Receptors, Purinergic P2X7 - metabolism | Mice | Reverse Transcriptase Inhibitors - therapeutic use | Alu Elements | Disease Models, Animal | Retinal Pigment Epithelium - drug effects | Prevention | Genetic research | Genetic aspects | Genetic transcription | Research | HIV (Viruses) | Virus research | Macular degeneration | Inhibitor drugs | Drug therapy | Ribonucleic acid--RNA | Human immunodeficiency virus--HIV | Atrophy | Drugs | Inhibitors | Ribonucleic acids | Blocking | Activation | Grafting
Journal Article